Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program
- PMID: 5694477
Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
